Quantitative Analysis of a Urine-Based Assay for Detection of Lipoarabinomannan in Patients with Tuberculosis-Reference-Cited by-同舟云学术

Quantitative Analysis of a Urine-Based Assay for Detection of Lipoarabinomannan in Patients with Tuberculosis

Published:2010-08 Issue:8 Volume:48 Page:2972-2974
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Shah Maunank¹,Martinson Neil A.¹²,Chaisson Richard E.¹,Martin Desmond J.³,Variava Ebrahim⁴,Dorman Susan E.¹

Affiliation:

1. Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Perinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa

3. Toga Laboratories, Johannesburg, South Africa, and Department of Medical Virology, University of Pretoria, South Africa

4. Tshepong Hospital, Northwest Department of Health, Klerksdorp, South Africa

Abstract

ABSTRACT Urinary lipoarabinomannan (LAM) detection is a promising approach for rapid diagnosis of active tuberculosis (TB). In microbiologically confirmed TB patients, quantitative LAM detection results increased progressively with bacillary burden and immunosuppression. Patients with disseminated TB and/or advanced HIV are target populations for whom urine LAM detection may be particularly useful.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00363-10

Reference17 articles.

1. Boehme, C., E. Molokova, F. Minja, S. Geis, T. Loscher, L. Maboko, V. Koulchin, and M. Hoelscher. 2005. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99 : 893-900.

2. Colebunders, R., and I. Bastian. 2000. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 4 : 97.

3. Daley, P., J. S. Michael, P. Hmar, A. Latha, P. Chordia, D. Mathai, K. R. John, and M. Pai. 2009. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int. J. Tuberc. Lung Dis. 13 : 989-995.

4. Dheda, K., V. Davids, L. Lenders, T. Roberts, R. Meldau, D. Ling, L. Brunet, R. van Zyl Smit, J. Peter, C. Green, M. Badri, L. Sechi, S. Sharma, M. Hoelscher, R. Dawson, A. Whitelaw, J. Blackburn, M. Pai, and A. Zumla. 2010. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 5 : e9848.

5. El-Sadr, W. M., and S. J. Tsiouris. 2008. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin. Respir. Crit. Care Med. 29 : 525-531.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of a sequence-specific Mtb -DNA hybridization assay in urine: a case-control study including subclinical TB cases;Microbiology Spectrum;2024-06-04

2. Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV;Cochrane Database of Systematic Reviews;2024-05-13

3. Diagnosis of extra pulmonary tuberculosis: An update on novel diagnostic approaches;Respiratory Medicine;2024-04

4. Diagnostic value of chemiluminescence for urinary lipoarabinomannan antigen assay in active tuberculosis: insights from a retrospective study;Frontiers in Cellular and Infection Microbiology;2023-12-08

5. Brief Report: Detection of Urine Lipoarabinomannan Is Associated With Proinflammatory Innate Immune Activation, Impaired Host Defense, and Organ Dysfunction in Adults With Severe HIV-Associated Tuberculosis in Uganda;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-05-01